Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.

<h4>Background</h4>Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study-a prospective cohort of people born in 1921 who turned 85 in 2006...

Full description

Saved in:
Bibliographic Details
Main Authors: Laurie E Davies, Andrew Kingston, Adam Todd, Barbara Hanratty
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245648&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849521449949200384
author Laurie E Davies
Andrew Kingston
Adam Todd
Barbara Hanratty
author_facet Laurie E Davies
Andrew Kingston
Adam Todd
Barbara Hanratty
author_sort Laurie E Davies
collection DOAJ
description <h4>Background</h4>Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study-a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845).<h4>Methods</h4>The prevalence of polypharmacy at baseline (mean age 85.5) was examined using cut-points of 0, 1, 2-4, 5-9 and ≥10 medicines-so-called 'no polypharmacy', 'monotherapy', 'minor polypharmacy', 'polypharmacy' and 'hyperpolypharmacy.' Cross-tabulations and upset plots identified the most frequently prescribed medicines and medication combinations within these categories. Mixed-effects models assessed whether gender and socioeconomic position were associated with prescribing changes over time (mean age 85.5-90.5). Participant characteristics were examined through descriptive statistics.<h4>Results</h4>Complex multimorbidity (44.4%, 344/775) was widespread but hyperpolypharmacy was not (16.0%, 135/845). The median medication count was six (interquartile range 4-8). Preventative medicines were common to all polypharmacy categories, and prescribing regimens were diverse. Nitrates and oral anticoagulants were more frequently prescribed for men, whereas bisphosphonates, non-opioid analgesics and antidepressants were more common in women. Cardiovascular medicines, including loop diuretics, tended to be more frequently prescribed for socioeconomically disadvantaged people (<25th centile Index of Multiple Deprivation (IMD)), despite no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) by IMD.<h4>Conclusion</h4>Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.
format Article
id doaj-art-b6351e20e88341c087f013efec640f4a
institution Kabale University
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-b6351e20e88341c087f013efec640f4a2025-08-20T03:25:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024564810.1371/journal.pone.0245648Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.Laurie E DaviesAndrew KingstonAdam ToddBarbara Hanratty<h4>Background</h4>Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study-a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845).<h4>Methods</h4>The prevalence of polypharmacy at baseline (mean age 85.5) was examined using cut-points of 0, 1, 2-4, 5-9 and ≥10 medicines-so-called 'no polypharmacy', 'monotherapy', 'minor polypharmacy', 'polypharmacy' and 'hyperpolypharmacy.' Cross-tabulations and upset plots identified the most frequently prescribed medicines and medication combinations within these categories. Mixed-effects models assessed whether gender and socioeconomic position were associated with prescribing changes over time (mean age 85.5-90.5). Participant characteristics were examined through descriptive statistics.<h4>Results</h4>Complex multimorbidity (44.4%, 344/775) was widespread but hyperpolypharmacy was not (16.0%, 135/845). The median medication count was six (interquartile range 4-8). Preventative medicines were common to all polypharmacy categories, and prescribing regimens were diverse. Nitrates and oral anticoagulants were more frequently prescribed for men, whereas bisphosphonates, non-opioid analgesics and antidepressants were more common in women. Cardiovascular medicines, including loop diuretics, tended to be more frequently prescribed for socioeconomically disadvantaged people (<25th centile Index of Multiple Deprivation (IMD)), despite no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) by IMD.<h4>Conclusion</h4>Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245648&type=printable
spellingShingle Laurie E Davies
Andrew Kingston
Adam Todd
Barbara Hanratty
Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
PLoS ONE
title Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
title_full Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
title_fullStr Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
title_full_unstemmed Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
title_short Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
title_sort characterising polypharmacy in the very old findings from the newcastle 85 study
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245648&type=printable
work_keys_str_mv AT laurieedavies characterisingpolypharmacyintheveryoldfindingsfromthenewcastle85study
AT andrewkingston characterisingpolypharmacyintheveryoldfindingsfromthenewcastle85study
AT adamtodd characterisingpolypharmacyintheveryoldfindingsfromthenewcastle85study
AT barbarahanratty characterisingpolypharmacyintheveryoldfindingsfromthenewcastle85study